> top > docs > PMC:2664230 > spans > 21746-22290 > annotations

PMC:2664230 / 21746-22290 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T8346 158-161 Protein denotes p65

2_test

Id Subject Object Predicate Lexical cue
18568240-12230568-22101135 187-189 12230568 denotes 33
18568240-8702838-22101136 403-404 8702838 denotes 9

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T9148 0-4 DT denotes This
T9149 5-10 NN denotes group
T9150 11-15 RB denotes also
T9151 16-28 VBD denotes demonstrated
T9152 29-33 IN denotes that
T9153 34-43 NN denotes forskolin
T9154 44-47 VBD denotes did
T9155 48-51 RB denotes not
T9156 52-59 VB denotes inhibit
T9157 60-63 DT denotes the
T9158 64-75 JJ denotes DNA-binding
T9159 76-84 NN denotes activity
T9160 85-87 IN denotes of
T9161 88-93 NNP denotes NF-κB
T9162 94-97 CC denotes and
T9163 98-102 IN denotes that
T9164 103-107 NNP denotes CREB
T9165 108-111 VBD denotes was
T9166 112-115 RB denotes not
T9167 116-124 VBN denotes involved
T9168 125-127 IN denotes in
T9169 128-145 JJ denotes forskolin-induced
T9170 146-154 NN denotes decrease
T9171 155-157 IN denotes in
T9172 158-161 CD denotes p65
T9173 162-177 JJ denotes transcriptional
T9174 178-186 NN denotes activity
T9175 186-189 CD denotes .33
T9176 190-197 JJ denotes Similar
T9177 198-205 NNS denotes results
T9178 206-210 VBD denotes were
T9179 211-219 VBN denotes reported
T9180 220-222 IN denotes by
T9181 223-231 NNP denotes Ollivier
T9182 232-234 FW denotes et
T9183 235-238 FW denotes al.
T9184 239-244 VBG denotes using
T9185 245-250 CD denotes THP-1
T9186 251-256 NNS denotes cells
T9187 257-260 CC denotes and
T9188 261-272 JJ denotes endothelial
T9189 273-278 NNS denotes cells
T9190 279-286 VBN denotes treated
T9191 287-291 IN denotes with
T9192 292-301 NN denotes forskolin
T9193 302-304 CC denotes or
T9194 305-314 NN denotes dibutyryl
T9195 315-319 NNP denotes cAMP
T9196 319-320 , denotes ,
T9197 321-324 CD denotes two
T9198 325-331 NNS denotes agents
T9199 332-337 VBN denotes known
T9200 338-340 TO denotes to
T9201 341-349 VB denotes function
T9202 350-357 IN denotes through
T9203 358-362 NNP denotes cAMP
T9204 363-372 NN denotes elevation
T9205 373-376 CC denotes and
T9206 377-387 JJ denotes subsequent
T9207 388-391 NNP denotes PKA
T9208 392-402 NN denotes activation
T9209 402-404 CD denotes .9
T9210 405-408 DT denotes The
T9211 409-420 NNS denotes differences
T9212 421-428 IN denotes between
T9213 429-432 PRP$ denotes our
T9214 433-440 NNS denotes results
T9215 441-444 CC denotes and
T9216 445-450 DT denotes those
T9217 451-460 VBN denotes mentioned
T9218 461-466 IN denotes above
T9219 467-470 MD denotes may
T9220 471-473 VB denotes be
T9221 474-483 VBN denotes explained
T9222 484-486 IN denotes by
T9223 487-490 DT denotes the
T9224 491-494 NN denotes use
T9225 495-497 IN denotes of
T9226 498-507 JJ denotes different
T9227 508-512 NN denotes cell
T9228 513-518 NNS denotes types
T9229 519-522 CC denotes and
T9230 523-532 JJ denotes exogenous
T9231 533-543 NNS denotes stimulants
T9232 543-544 . denotes .
R7569 T9148 T9149 det This,group
R7570 T9149 T9151 nsubj group,demonstrated
R7571 T9150 T9151 advmod also,demonstrated
R7572 T9151 T9151 ROOT demonstrated,demonstrated
R7573 T9152 T9156 mark that,inhibit
R7574 T9153 T9156 nsubj forskolin,inhibit
R7575 T9154 T9156 aux did,inhibit
R7576 T9155 T9156 neg not,inhibit
R7577 T9156 T9151 ccomp inhibit,demonstrated
R7578 T9157 T9159 det the,activity
R7579 T9158 T9159 amod DNA-binding,activity
R7580 T9159 T9156 dobj activity,inhibit
R7581 T9160 T9159 prep of,activity
R7582 T9161 T9160 pobj NF-κB,of
R7583 T9162 T9156 cc and,inhibit
R7584 T9163 T9167 mark that,involved
R7585 T9164 T9167 nsubjpass CREB,involved
R7586 T9165 T9167 auxpass was,involved
R7587 T9166 T9167 neg not,involved
R7588 T9167 T9156 conj involved,inhibit
R7589 T9168 T9167 prep in,involved
R7590 T9169 T9170 amod forskolin-induced,decrease
R7591 T9170 T9168 pobj decrease,in
R7592 T9171 T9170 prep in,decrease
R7593 T9172 T9174 nummod p65,activity
R7594 T9173 T9174 amod transcriptional,activity
R7595 T9174 T9171 pobj activity,in
R7596 T9175 T9177 nummod .33,results
R7597 T9176 T9177 amod Similar,results
R7598 T9177 T9179 nsubjpass results,reported
R7599 T9178 T9179 auxpass were,reported
R7600 T9179 T9151 conj reported,demonstrated
R7601 T9180 T9179 agent by,reported
R7602 T9181 T9180 pobj Ollivier,by
R7603 T9182 T9183 nmod et,al.
R7604 T9183 T9184 npadvmod al.,using
R7605 T9184 T9179 advcl using,reported
R7606 T9185 T9186 nummod THP-1,cells
R7607 T9186 T9184 dobj cells,using
R7608 T9187 T9186 cc and,cells
R7609 T9188 T9189 amod endothelial,cells
R7610 T9189 T9186 conj cells,cells
R7611 T9190 T9186 acl treated,cells
R7612 T9191 T9190 prep with,treated
R7613 T9192 T9191 pobj forskolin,with
R7614 T9193 T9192 cc or,forskolin
R7615 T9194 T9195 compound dibutyryl,cAMP
R7616 T9195 T9192 conj cAMP,forskolin
R7617 T9196 T9195 punct ",",cAMP
R7618 T9197 T9198 nummod two,agents
R7619 T9198 T9195 appos agents,cAMP
R7620 T9199 T9198 acl known,agents
R7621 T9200 T9201 aux to,function
R7622 T9201 T9199 xcomp function,known
R7623 T9202 T9201 prep through,function
R7624 T9203 T9204 compound cAMP,elevation
R7625 T9204 T9202 pobj elevation,through
R7626 T9205 T9204 cc and,elevation
R7627 T9206 T9208 amod subsequent,activation
R7628 T9207 T9208 compound PKA,activation
R7629 T9208 T9204 conj activation,elevation
R7630 T9209 T9208 nummod .9,activation
R7631 T9210 T9211 det The,differences
R7632 T9211 T9201 dobj differences,function
R7633 T9212 T9211 prep between,differences
R7634 T9213 T9214 poss our,results
R7635 T9214 T9212 pobj results,between
R7636 T9215 T9214 cc and,results
R7637 T9216 T9214 conj those,results
R7638 T9217 T9216 acl mentioned,those
R7639 T9218 T9217 advmod above,mentioned
R7640 T9219 T9221 aux may,explained
R7641 T9220 T9221 auxpass be,explained
R7642 T9221 T9151 conj explained,demonstrated
R7643 T9222 T9221 agent by,explained
R7644 T9223 T9224 det the,use
R7645 T9224 T9222 pobj use,by
R7646 T9225 T9224 prep of,use
R7647 T9226 T9228 amod different,types
R7648 T9227 T9228 compound cell,types
R7649 T9228 T9225 pobj types,of
R7650 T9229 T9228 cc and,types
R7651 T9230 T9231 amod exogenous,stimulants
R7652 T9231 T9228 conj stimulants,types
R7653 T9232 T9151 punct .,demonstrated

GO-BP

Id Subject Object Predicate Lexical cue
T9859 162-177 http://purl.obolibrary.org/obo/GO_0006351 denotes transcriptional
T9898 388-391 http://purl.obolibrary.org/obo/GO_0004691 denotes PKA

GO-MF

Id Subject Object Predicate Lexical cue
T10039 388-391 http://purl.obolibrary.org/obo/GO_0004691 denotes PKA
T10050 64-75 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA-binding
T10054 68-75 http://purl.obolibrary.org/obo/GO_0005488 denotes binding

GO-CC

Id Subject Object Predicate Lexical cue
T10066 251-256 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T10067 273-278 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T10075 388-391 http://purl.obolibrary.org/obo/GO_0005952 denotes PKA

sentences

Id Subject Object Predicate Lexical cue
T8392 0-544 Sentence denotes This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants.
T148 0-544 Sentence denotes This group also demonstrated that forskolin did not inhibit the DNA-binding activity of NF-κB and that CREB was not involved in forskolin-induced decrease in p65 transcriptional activity.33 Similar results were reported by Ollivier et al. using THP-1 cells and endothelial cells treated with forskolin or dibutyryl cAMP, two agents known to function through cAMP elevation and subsequent PKA activation.9 The differences between our results and those mentioned above may be explained by the use of different cell types and exogenous stimulants.

events-check-again

Id Subject Object Predicate Lexical cue
T10629 158-161 Protein denotes p65

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T10218 88-93 Protein denotes NF-κB
T10219 103-107 Protein denotes CREB
T10220 158-161 Protein denotes p65
T10221 388-391 Protein denotes PKA
T10222 52-59 Negative_regulation denotes inhibit
T10223 146-154 Negative_regulation denotes decrease
R8283 T10218 T10222 themeOf NF-κB,inhibit
R8284 T10220 T10223 themeOf p65,decrease

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T9742 103-107 Q8TEY5 denotes CREB
T9743 103-107 Q02930 denotes CREB
T9744 103-107 P18848 denotes CREB
T9745 103-107 P16220 denotes CREB
T9746 103-107 P15336 denotes CREB
T9747 103-107 O43889 denotes CREB
T9748 158-161 P21579 denotes p65
T9749 158-161 Q04206 denotes p65

test2

Id Subject Object Predicate Lexical cue
T8243 138-145 Positive_regulation denotes induced
T8244 146-154 Negative_regulation denotes decrease
T8245 158-161 Protein denotes p65
T8246 162-177 Transcription denotes transcriptional
R6753 T8244 T8243 themeOf decrease,induced
R6754 T8245 T8246 themeOf p65,transcriptional
R6755 T8246 T8244 themeOf transcriptional,decrease